Date published: 2025-11-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR4K15 Inhibitors

OR4K15 inhibitors function through various biochemical mechanisms to affect the signaling and activity of this olfactory receptor. Metals such as copper and zinc act as allosteric modulators, binding to specific sites on the receptor that can impair ligand binding or receptor conformation. The receptor's activity is also contingent on the proper membrane environment; cholesterol extraction by certain compounds disrupts the lipid raft domains, leading to a decrease in receptor function. Additionally, altering intracellular cAMP levels can desensitize the receptor, thereby reducing its activity. Other inhibitors operate by interfering with the G-protein signaling cascade. For instance, some compounds can inhibit specific G-protein subunits or disrupt the association between G-proteins and their coupled receptors, leading to an attenuation of the receptor's signaling efficacy.

Furthermore, some inhibitors target the recycling and internalization processes of G-protein-coupled receptors, which are essential for receptor resensitization and response to new stimuli. Toxins that target G-proteins can inhibit the receptor's signaling by preventing the activation of downstream effectors. Certain blockers that target related receptor families can indirectly influence OR4K15 by modulating the shared signaling pathways. Inhibitors of other G-protein-coupled receptors, such as cannabinoid or vanilloid receptors, may also have off-target effects that reduce the functional activity of OR4K15. Finally, a few compounds can inhibit signaling molecules that act downstream of the receptor, which is critical for the full cellular response to the receptor's activation, thereby effectively reducing the receptor's functionality without directly interacting with the receptor itself.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Copper(II) sulfate

7758-98-7sc-211133
sc-211133A
sc-211133B
100 g
500 g
1 kg
$45.00
$120.00
$185.00
3
(1)

Copper ions bind to histidine residues on G-protein coupled receptors, which could impair the ligand binding on OR4K15.

Zinc

7440-66-6sc-213177
100 g
$47.00
(0)

Zinc ions have been shown to act as allosteric inhibitors of G-protein-coupled receptors, potentially affecting OR4K15.

Methyl-β-cyclodextrin

128446-36-6sc-215379A
sc-215379
sc-215379C
sc-215379B
100 mg
1 g
10 g
5 g
$25.00
$65.00
$170.00
$110.00
19
(1)

Removes cholesterol from cell membranes, possibly disrupting the membrane environment essential for OR4K15 function.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Activates adenylate cyclase, increasing cAMP levels which can desensitize G-protein coupled receptors like OR4K15.

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

As a beta-adrenergic antagonist, it may interfere with G-protein signaling cascades that OR4K15 is a part of.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Alters the acidity of intracellular vesicles, potentially impairing G-protein receptor recycling including that of OR4K15.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$442.00
3
(1)

Inhibits Gi/o proteins, which could disrupt downstream signaling of OR4K15.

Capsazepine

138977-28-3sc-201098
sc-201098A
5 mg
25 mg
$145.00
$450.00
11
(1)

Blocks vanilloid receptors, which may indirectly affect G-protein receptor mediated pathways that OR4K15 participates in.

JTE 907

282089-49-0sc-203616
sc-203616A
10 mg
50 mg
$283.00
$1100.00
(0)

Inhibits the cannabinoid receptor 1 (CB1), could indirectly affect the signaling pathways associated with OR4K15.

YM 254890

568580-02-9sc-507356
1 mg
$500.00
(0)

Specific Gαq inhibitor, could disrupt signaling pathways downstream of OR4K15.